We've found
					11,964 Cardiology				
					clinical trials				
				
			
		
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Orthopedics / Podiatry, Other Clinical Trial
	Treatment of Post-SCI Hypotension
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Orthopedics / Podiatry, Other Clinical Trial
	Treatment of Post-SCI Hypotension
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 2)
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 2)
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Functional Single Ventricle Heart Disease Clinical Trial
	A Extension Study of Udenafil in Adolescents
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Functional Single Ventricle Heart Disease Clinical Trial
	A Extension Study of Udenafil in Adolescents
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Functional Single Ventricle Heart Disease Clinical Trial
	A Extension Study of Udenafil in Adolescents
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Functional Single Ventricle Heart Disease Clinical Trial
	A Extension Study of Udenafil in Adolescents
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Carotid Artery Stenosis Clinical Trial
	Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
		Status: Enrolling
  
							
  	
	Carotid Artery Stenosis Clinical Trial
	Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Carotid Artery Stenosis Clinical Trial
	Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
		Status: Enrolling
  
							
  	
	Carotid Artery Stenosis Clinical Trial
	Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
	INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
	INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
	INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
	INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
	INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
	INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
	INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
	INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Atherosclerotic Cardiovascular Disease Clinical Trial
	Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
		Status: Enrolling
  
							
  	
	Atherosclerotic Cardiovascular Disease Clinical Trial
	Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Atherosclerotic Cardiovascular Disease Clinical Trial
	Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
		Status: Enrolling
  
							
  	
	Atherosclerotic Cardiovascular Disease Clinical Trial
	Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Validation of Simple Acute Coronary Syndrome (SACS) Score
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Validation of Simple Acute Coronary Syndrome (SACS) Score
		Status: Enrolling	
	
	
			Updated: 7/18/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
	National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
		Status: Enrolling,
							Phase
  
							
  	
	Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
	National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 4/9/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Randomized Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Randomized Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Randomized Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Randomized Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Carotid Artery Disease Clinical Trial
	SVS VQI TransCarotid Revascularization Surveillance Project
		Status: Enrolling,
							Phase
  
							
  	
	Carotid Artery Disease Clinical Trial
	SVS VQI TransCarotid Revascularization Surveillance Project
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	CardiAMP™ Heart Failure Trial
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	CardiAMP™ Heart Failure Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Deep Venous Thrombosis Clinical Trial
	Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Trial
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Deep Venous Thrombosis Clinical Trial
	Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Trial
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Neurology Clinical Trial
	EDS in Ataxia Telangiectasia Patients
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Neurology Clinical Trial
	EDS in Ataxia Telangiectasia Patients
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Aortic Stenosis Clinical Trial
	The PARTNER 3 - Trial - The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Aortic Stenosis Clinical Trial
	The PARTNER 3 - Trial - The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Aortic Stenosis Clinical Trial
	The PARTNER 3 - Trial - The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Aortic Stenosis Clinical Trial
	The PARTNER 3 - Trial - The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Coronary Artery Disease Clinical Trial
	RESOLUTE ONYX Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Coronary Artery Disease Clinical Trial
	RESOLUTE ONYX Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
		Status: Enrolling,
							Phase
  
							
  	
	Heart Failure Clinical Trial
	Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
		Status: Enrolling,
							Phase
  
							
  	
	Heart Failure Clinical Trial
	Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Congenital Heart Defect Clinical Trial
	Exclusive Human Milk Feeding in Infants With Single Ventricle Physiology
		Status: Enrolling
  
							
  	
	Congenital Heart Defect Clinical Trial
	Exclusive Human Milk Feeding in Infants With Single Ventricle Physiology
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	The PARTNER 3 - AVIV Trial
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	The PARTNER 3 - AVIV Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure,Congestive Clinical Trial
	Effect of mechanIcal circulatoRy Support ON Exercise Capacity aMong pAtieNts With Heart Failure
		Status: Enrolling,
							Phase
  
							
  	
	Heart Failure,Congestive Clinical Trial
	Effect of mechanIcal circulatoRy Support ON Exercise Capacity aMong pAtieNts With Heart Failure
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Acute Myocardial Infarction Clinical Trial
	Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Acute Myocardial Infarction Clinical Trial
	Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Heart Failure With Preserved Systolic Function Clinical Trial
	Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Chronic Heart Failure With Preserved Systolic Function Clinical Trial
	Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Heart Failure With Preserved Systolic Function Clinical Trial
	Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Chronic Heart Failure With Preserved Systolic Function Clinical Trial
	Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Heart Failure With Preserved Systolic Function Clinical Trial
	Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Chronic Heart Failure With Preserved Systolic Function Clinical Trial
	Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 
  
						
				
			
We've found
					11,964 Cardiology
				
					clinical trials
				
				
				
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Orthopedics / Podiatry, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Treatment of Post-SCI Hypotension
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 2)
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Functional Single Ventricle Heart Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Extension Study of Udenafil in Adolescents
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Functional Single Ventricle Heart Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Extension Study of Udenafil in Adolescents
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Carotid Artery Stenosis Clinical Trial
	
Updated: 12/31/1969
  
  
  Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Carotid Artery Stenosis Clinical Trial
	
Updated: 12/31/1969
  
  
  Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Atherosclerotic Cardiovascular Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Atherosclerotic Cardiovascular Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 7/18/2016
  
  
  Validation of Simple Acute Coronary Syndrome (SACS) Score
		Status: Enrolling	
	Updated: 7/18/2016
Click here to add this to my saved trials
	    
	 
  	
	Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
	
Updated: 4/9/2018
  
  
  National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 4/9/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Carotid Artery Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  SVS VQI TransCarotid Revascularization Surveillance Project
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  CardiAMP™ Heart Failure Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Deep Venous Thrombosis Clinical Trial
	
Updated: 12/31/1969
  
  
  Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Trial
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Neurology Clinical Trial
	
Updated: 12/31/1969
  
  
  EDS in Ataxia Telangiectasia Patients
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Aortic Stenosis Clinical Trial
	
Updated: 12/31/1969
  
  
  The PARTNER 3 - Trial - The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Aortic Stenosis Clinical Trial
	
Updated: 12/31/1969
  
  
  The PARTNER 3 - Trial - The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Coronary Artery Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  RESOLUTE ONYX Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Congenital Heart Defect Clinical Trial
	
Updated: 12/31/1969
  
  
  Exclusive Human Milk Feeding in Infants With Single Ventricle Physiology
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	
Updated: 12/31/1969
  
  
  The PARTNER 3 - AVIV Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure,Congestive Clinical Trial
	
Updated: 12/31/1969
  
  
  Effect of mechanIcal circulatoRy Support ON Exercise Capacity aMong pAtieNts With Heart Failure
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Acute Myocardial Infarction Clinical Trial
	
Updated: 12/31/1969
  
  
  Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Chronic Heart Failure With Preserved Systolic Function Clinical Trial
	
Updated: 12/31/1969
  
  
  Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Chronic Heart Failure With Preserved Systolic Function Clinical Trial
	
Updated: 12/31/1969
  
  
  Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Chronic Heart Failure With Preserved Systolic Function Clinical Trial
	
Updated: 12/31/1969
  
  
  Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	